Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

All eyes were on Crown Princess Mette-Marit of Norway during an unexpected family reunion on Friday. The nation’s future ...

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...

The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...

A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...

This Nature Outlook is editorially independent, produced with financial support from Boehringer Ingelheim. About this content. Humans can’t survive without taking a breath. And the lungs are the ...

Please provide your email address to receive an email when new articles are posted on . Researchers captured exercise capacity measures during the first week of pulmonary rehabilitation to the session ...

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...